Compare Illumina, Inc. (ILMN) vs Monster Beverage Corp (MNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Monster Beverage Corp — how do they compare? Illumina, Inc. trades at $189.79 (market cap $27.94B), while Monster Beverage Corp trades at $94.08 (market cap $93.35B). The key difference: Monster Beverage Corp is far larger — about 3.3× Illumina, Inc.'s market cap. Which is the better fit depends on your goals.
| ILMN | MNST | |
|---|---|---|
Market Cap | $27.94B | $93.35B |
Sector | Health | Consumer Staples |
52-Week High | $194.33 | $99.94 |
52-Week Low | $91.00 | $58.75 |
Enterprise Value | $29.33B | $91.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Monster Beverage (MNST) trades at $95.79, down 1.75% over 24 hours but near its 52-week high of $99.53. The stock shows strong fundamentals with consistent earnings beats, revenue growth to $8.29B in 2025, and robust profitability margins. A 2-for-1 stock split announced for August 2026 reflects confidence, while technical indicators signal a bullish trend with support at $94.
Outlook remains positive driven by international expansion and product innovation, with a consensus price target of $97.83 offering modest upside. Risks include high valuation multiples and competitive pressures in the energy drink sector. Analyst sentiment is predominantly bullish, supporting a favorable investment case for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →
